
Photo taken from Chien-Chin Lin/Researchgate
Aug 1, 2024, 03:00
IDH2 mutation accelerates TPO-induced myelofibrosis
Yu-Hung Wang, PhD student at The University of Manchester, shared a post on X about a recent paper by Chien-Chin Lin et al., commenting:
“IDH2 mutation accelerates thrombopoietin (TPO) induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo.”
IDH2 mutation accelerates TPO-induced myelofibrosis with enhanced S100a8/a9 and NFκB signaling in vivo published in Wiley Online Library.
Authors: Chien-Chin Lin, Chi-Yuan Yao, Yu-Hung Wang, Yueh-Chwen Hsu, Chang-Tsu Yuan, Tsung-Chih Chen, Chia-Lang Hsu, Sze-Hwei Lee, Jhih-Yi Lee, Pin-Tsen Shih, Chein-Jun Kao, Po-Han Chuang, Yuan-Yeh Kuo, Hsin-An Hou, Wen-Chien Chou, Hwei-Fang Tien.
Additional information
Source: Yu-Hung Wang/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20